Your browser doesn't support javascript.
loading
Biomimetic Nanodisks Are Effective Against Tubulointerstitial Fibrosis via Targeting Interstitial Microenvironment.
Zhou, Chuchu; Tang, Rou; Tan, Huajin; Yang, Yige; Meng, Peipei; Li, He; Song, Kaichao; Tan, Xiaochuan; Guo, Xiuping; Ren, Ling; He, Shuwang; Meng, Ya; Hao, Yumei; Lin, Mingbao; Zhang, Yujia; Huang, Hongdong; Wang, Lulu; Zheng, Wensheng.
Affiliation
  • Zhou C; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Tang R; Clinical Research Center, Beijing Children's Hospital, National Center for Children's Health (C.Z.), Capital Medical University, China.
  • Tan H; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Yang Y; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Meng P; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Li H; Department of Nephrology, Beijing Friendship Hospital, Faculty of Kidney Diseases (P.M., H.H.), Capital Medical University, China.
  • Song K; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (P.M.).
  • Tan X; Beijing Tiantan Hospital (H.L.), Capital Medical University, China.
  • Guo X; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Ren L; Institute of Medicinal Biotechnology (K.S., X.G., L.R., L.W.), Chinese Academy of Medical Sciences and Peking Union Medical College, China.
  • He S; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Meng Y; Institute of Medicinal Biotechnology (K.S., X.G., L.R., L.W.), Chinese Academy of Medical Sciences and Peking Union Medical College, China.
  • Hao Y; Institute of Medicinal Biotechnology (K.S., X.G., L.R., L.W.), Chinese Academy of Medical Sciences and Peking Union Medical College, China.
  • Lin M; Shandong DYNE Marine Biopharmaceutical Co, Ltd, Rongcheng, China (S.H.).
  • Zhang Y; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Huang H; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Wang L; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Zheng W; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
Circ Res ; 135(6): e150-e153, 2024 Aug 30.
Article in En | MEDLINE | ID: mdl-39092524
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrosis / Biomimetic Materials Limits: Animals / Humans Language: En Journal: Circ Res Year: 2024 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrosis / Biomimetic Materials Limits: Animals / Humans Language: En Journal: Circ Res Year: 2024 Document type: Article Country of publication: United States